Manufacturing Inspection. At any time prior to BMS’s exercise of the Option, BMS shall have the right, but not the obligation, at BMS’s reasonable cost and expense, to conduct due diligence with respect to BN’s and its Affiliates’ manufacturing and supply capability of clinical and/or commercial quantities of the Product if and as may be requested by BMS. Without limiting the generality of the foregoing, BMS shall have the right to inspect and audit, itself and/or with or through any of its Affiliates, independent contractors and/or representatives reasonably acceptable to BN and subject to confidentiality obligations in a form reasonably acceptable to both Parties, all facilities used or proposed to be used by BN and/or its Affiliates for any Product manufacturing or related activities (each, a “Manufacturing Facility”) (including with respect to technical, quality, environmental, health and safety (EHS), compliance and capacity) and the right to observe generally BN’s and its Affiliates’ ordinary manufacturing processes (including any manufacturing activities conducted in connection with the PROSPECT Trial). BN shall assist and cooperate with BMS in connection with such diligence process as may be requested by BMS, and BN shall provide access to the Manufacturing Facilities to BMS and its Affiliates, independent contractors and representatives during normal business hours and upon reasonable notice, and BN shall ensure that its Affiliates and any Third Party contractors shall, make available to BMS (and its designees), its employees and independent contractors, and all permits, licenses, inspection reports, records and all other Information related to such Manufacturing Facilities and/or, more generally, to the manufacture of any Product.
Manufacturing Inspection. Gen-Probe shall have the right, upon reasonable prior notice, to inspect all phases of the Instrument manufacturing activities, during normal business hours, in order to verify KMC's compliance with production specifications and regulatory standards. KMC agrees to give Gen-Probe access, during normal working hours and upon reasonable prior notice, to such records as are reasonably necessary to confirm KMC's compliance with its manufacturing obligations hereunder including quality control records, test records, manufacturing records and design records, and to permit Gen-Probe to review and copy such records. All such records shall be held by Gen-Probe in accordance with the terms of the confidentiality provisions of Article XIII.
Manufacturing Inspection. Seller will apply its normal quality control procedures in manufacturing Products. Seller shall attempt to accommodate requests by Buyer to observe manufacturing and/or testing of Products, subject to appropriate access restrictions, if such observation can be arranged without delaying the work.
Manufacturing Inspection. QTX shall have the right, upon reasonable prior notice, in no event shorter than fifteen (15) business days, to inspect all phases of the Instrument manufacturing activities, during normal Business Hours, in order to verify STRATEC’s compliance with production specifications and regulatory standards.
Manufacturing Inspection. Gen-Probe shall have the right, upon reasonable prior notice, to inspect all phases of the Instrument manufacturing activities, during normal business hours, in order to verify STRATEC’s compliance with production specifications and regulatory standards. STRATEC agrees to give Gen-Probe access, during normal working hours and upon reasonable prior notice, to such records as are reasonably necessary to confirm STRATEC’s compliance with its manufacturing obligations hereunder including quality control records, test records, manufacturing records and design records, and to permit Gen-Probe to review and copy such records. All such records shall be held by Gen-Probe in accordance with the terms of the confidentiality provisions of Article 11.
Manufacturing Inspection. QTX shall have the right, upon reasonable prior notice, in no event shorter than fifteen (15) business days, to inspect all phases of the Instrument manufacturing activities, during normal Business Hours, in order to verify STRATEC’s compliance with production specifications and regulatory standards. Portions of this Exhibit, indicated by the xxxx “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended.
